Brain Visual Perception Training for Prevention and Control of Premyopia
Launched by SHANGHAI EYE DISEASE PREVENTION AND TREATMENT CENTER · Sep 3, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to help prevent myopia, or nearsightedness, in children who are at risk of developing it. The researchers want to see if a special training program that helps improve how the brain processes visual information can slow down the growth of myopia in children aged 6 to 10 years. They will compare children who participate in this brain training with a control group that does not receive the training to determine if it really makes a difference in preventing the onset of myopia.
To join the study, children must be between 6 and 10 years old and have early signs of myopia, defined by specific measurements of their eyesight. However, children with certain eye conditions or other health issues will not be eligible. Participants in the trial will undergo 20 minutes of brain visual perception training each day for a year and will have check-ups at the hospital every three months to monitor their progress. This trial is still in the planning stages and has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 6-10 years with premyopia, defined as a cycloplegic spherical equivalent refraction (SER) of the more myopic eye in the range of -0.50 to 0.75 (inclusive) diopters (D) and having at least 1parent with an SER in either eye of -3.00D or less.
- Exclusion Criteria:
- • Children have astigmatism of 1.50D or more, anisometropia of 1.50 D or more, strabismus and other ocular abnormalities, any systemic diseases, or a history of any myopia interventions.
About Shanghai Eye Disease Prevention And Treatment Center
The Shanghai Eye Disease Prevention and Treatment Center is a leading clinical research organization dedicated to advancing the understanding and treatment of ocular diseases. With a strong emphasis on innovation and patient-centered care, the center collaborates with various stakeholders, including academic institutions and healthcare providers, to conduct rigorous clinical trials. Its mission is to enhance eye health outcomes through evidence-based research, contributing to the global body of knowledge in ophthalmology. The center is committed to fostering a culture of excellence in clinical practices, ensuring the highest standards of safety and efficacy in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported